Regenerative Medicine Innovation Projects

APPLY HERE: RFA-HL-17-023 
                        RFA-HL-17-024

Applications Due June 26, 2017

NHLBI small business awardees are eligible to apply for a competing revision to your current award. The Regenerative Medicine Innovation Project (RMIP), will support revision projects that propose solutions to widely recognized issues in the development of safe and effective regenerative medicine therapies.  

Awards are anticipated in FY 2017

To learn more about this opportunity, please read the full announcement RFA-HL-17-023 R43/R44 (SBIR) or RFA-HL-17-024 R41/R42 (STTR). 

The NHLBI SBIR/STTR Programs provide support for small businesses developing and commercializing novel technologies and products to prevent, diagnose and treat heart, lung, blood, and sleep diseases and disorders. The NHLBI provides grant and contract funding for research and development of technologies related to the mission of NHLBI. For more information about the NHLBI SBIR/STTR Program, including funding opportunities, visit our web page.

NHLBI Small Biz Inquiry Form                                                              @NHLBI_SBIR